(R)-N-Boc-2-(hydroxymethyl)morpholine - CAS 135065-71-3
Catalog: |
BB008065 |
Product Name: |
(R)-N-Boc-2-(hydroxymethyl)morpholine |
CAS: |
135065-71-3 |
Synonyms: |
(2R)-2-(hydroxymethyl)-4-morpholinecarboxylic acid tert-butyl ester; tert-butyl (2R)-2-(hydroxymethyl)morpholine-4-carboxylate |
IUPAC Name: | tert-butyl (2R)-2-(hydroxymethyl)morpholine-4-carboxylate |
Description: | (R)-N-Boc-2-(hydroxymethyl)morpholine (CAS# 135065-71-3) is used for preparation of inhibitors of Checkpoint Kinase 1 through template screening. |
Molecular Weight: | 217.26 |
Molecular Formula: | C10H19NO4 |
Canonical SMILES: | CC(C)(C)OC(=O)N1CCOC(C1)CO |
InChI: | InChI=1S/C10H19NO4/c1-10(2,3)15-9(13)11-4-5-14-8(6-11)7-12/h8,12H,4-7H2,1-3H3/t8-/m1/s1 |
InChI Key: | FJYBLMJHXRWDAQ-MRVPVSSYSA-N |
Boiling Point: | 321 °C |
Density: | 1.118 g/cm3 |
Appearance: | Solid |
Storage: | Inert atmosphere, 2-8 °C |
MDL: | MFCD09260605 |
LogP: | 0.55250 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021207210-A1 | Methods for synthesis of chk1 inhibitors | 20200407 |
WO-2021198020-A1 | 3-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancer | 20200331 |
WO-2021194878-A1 | Selective modulators of mutant lrrk2 proteolysis and associated methods of use | 20200321 |
WO-2021161105-A1 | P2x3 modulators | 20200214 |
WO-2021161109-A1 | Preparation of a p2x3 antagonist | 20200214 |
PMID | Publication Date | Title | Journal |
18363360 | 20080502 | Concise synthesis of (S)-N-BOC-2-hydroxymethylmorpholine and (S)-N-BOC-morpholine-2-carboxylic acid | The Journal of organic chemistry |
Complexity: | 224 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 1 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 217.13140809 |
Formal Charge: | 0 |
Heavy Atom Count: | 15 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 217.13140809 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 59 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.1 |
-
Catalog: BB026447
(±)-3-Benzyloxy-1,2-propanediol
Detail
-
Catalog: BB052021
(1-Cyclopentyl-1H-pyrazol-5-yl)methanol
Detail
-
Catalog: BB000572
(1-Boc-azetidine-3,3-diyl)dimethanol
Detail
-
Catalog: BB051687
(1-(2,2,2-Trifluoroethyl)-1H-pyrazol-5-yl)methanol
Detail
-
Catalog: BB017049
(1-Allylcyclobutyl)methanol
Detail
-
Catalog: BB054256
((2S,4R)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol
Detail
-
Catalog: BB078849
((2S,4S)-1-benzyl-4-((tert-butyldimethylsilyl)oxy)pyrrolidin-2-yl)methanol
Detail
-
Catalog: BB078864
((2R,5R)-5-methylpiperazin-2-yl)methanol dihydrochloride
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Alcohols and Derivatives
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS